(Q34094500)

31 July 2017

title

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue (English)

1 reference

31 July 2017

A A Patchett

1

1 reference

31 July 2017

R P Nargund

2

1 reference

31 July 2017

J R Tata

3

1 reference

31 July 2017

M H Chen

4

1 reference

31 July 2017

K J Barakat

5

1 reference

31 July 2017

D B Johnston

6

1 reference

31 July 2017

K Cheng

7

1 reference

31 July 2017

W W Chan

8

1 reference

31 July 2017

B Butler

9

1 reference

31 July 2017

G Hickey

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

31 July 2017

number of pages

5

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

31 July 2017

volume

92

1 reference

31 July 2017

issue

15

1 reference

31 July 2017

page(s)

7001-7005

1 reference

A nonpeptidyl growth hormone secretagogue

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Novel tetracyclic spiropiperidines. 3. 1-arylspiro[indoline-3,4'-piperidine]s as potential antidepressants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Molecular conformation and biological activity of central nervous system active drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Evidence for a Role of Protein Kinase-C in His-D-Trp Ala-Trp-D-Phe-Lys-NH2-Induced Growth Hormone Release from Rat Primary Pituitary Cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Spiropiperidines as high-affinity, selective .sigma. ligands

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

Untoward Events in Patients Treated with Growth Hormone in the USA

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41459

GH releasing peptides--structure and kinetics

28 October 2018

1 reference

12 December 2020

Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles

1 reference

12 December 2020

Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6

1 reference

12 December 2020

Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)

1 reference

12 December 2020

On a peptidomimetic growth hormone-releasing peptide

1 reference

12 December 2020

Central actions of peptide and non-peptide growth hormone secretagogues in the rat

1 reference

12 December 2020

Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*

1 reference

12 December 2020

Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay

1 reference

12 December 2020

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

1 reference

12 December 2020

Orally active, nonpeptide oxytocin antagonists

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.92.15.7001

1 reference

31 July 2017

0 references

1 reference

31 July 2017

1 reference